Clearside Biomedical, Inc.CLSDNASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank8
Year-over-Year Change
Year-over-year operating income growth rate
Percentile
P8
Near historical low
vs 5Y Ago
-1.7x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -97.31% |
| Q2 2025 | 31.45% |
| Q1 2025 | 27.19% |
| Q4 2024 | -20.48% |
| Q3 2024 | 21.82% |
| Q2 2024 | 7.54% |
| Q1 2024 | -181.61% |
| Q4 2023 | 58.68% |
| Q3 2023 | 2.97% |
| Q2 2023 | 4.40% |
| Q1 2023 | 5.76% |
| Q4 2022 | -20.02% |
| Q3 2022 | 14.20% |
| Q2 2022 | -2.50% |
| Q1 2022 | -140.87% |
| Q4 2021 | 482.63% |
| Q3 2021 | 19.80% |
| Q2 2021 | 26.99% |
| Q1 2021 | -17.43% |
| Q4 2020 | -192.35% |
| Q3 2020 | 56.24% |
| Q2 2020 | -95.94% |
| Q1 2020 | 5.87% |
| Q4 2019 | 52.69% |
| Q3 2019 | -13.37% |
| Q2 2019 | 63.30% |
| Q1 2019 | 29.24% |
| Q4 2018 | 9.70% |
| Q3 2018 | -14.60% |
| Q2 2018 | -27.05% |
| Q1 2018 | -0.81% |
| Q4 2017 | 10.29% |
| Q3 2017 | -33.40% |
| Q2 2017 | -32.98% |
| Q1 2017 | -9.61% |
| Q4 2016 | -76.35% |
| Q3 2016 | -2.47% |
| Q2 2016 | 3.34% |
| Q1 2016 | -6.80% |
| Q4 2015 | -48.67% |